THERAPURE BIOLOGICS Trademark

Trademark Overview

On Monday, June 8, 2015, a trademark application was filed for THERAPURE BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the THERAPURE BIOLOGICS trademark a serial number of 86655356. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, April 1, 2020. This trademark is owned by Therapure Biopharma Inc.. The THERAPURE BIOLOGICS trademark is filed in the Pharmaceutical Products and Treatment & Processing of Materials Services categories with the following description:

pharmaceutical preparations in the nature of biologics, biopharmaceuticals, and drugs, all derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use, to treat acute and chronic medical conditions; pharmaceutical preparations in the nature of biologics, biopharmaceuticals, drugs derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins

Manufacturing services for others in the field of biologics, namely, contract manufacturing and/or toll manufacturing of plasma derived biologics from human blood, human plasma, cryopaste, and cryoprecipitate for research and development and clinical use; consulting in the field of manufacturing practices and facilities for pharmaceutical preparations related to biologics derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use
therapure biologics

General Information

Serial Number86655356
Word MarkTHERAPURE BIOLOGICS
Filing DateMonday, June 8, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, April 1, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOLOGICS"
Description of MarkThe mark consists of the stylized wording "THERAPURE BIOLOGICS" next to several dots creating three incomplete arrows.
Goods and Servicespharmaceutical preparations in the nature of biologics, biopharmaceuticals, and drugs, all derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use, to treat acute and chronic medical conditions; pharmaceutical preparations in the nature of biologics, biopharmaceuticals, drugs derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins
Goods and ServicesManufacturing services for others in the field of biologics, namely, contract manufacturing and/or toll manufacturing of plasma derived biologics from human blood, human plasma, cryopaste, and cryoprecipitate for research and development and clinical use; consulting in the field of manufacturing practices and facilities for pharmaceutical preparations related to biologics derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 11, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, June 11, 2015
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTherapure Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N8H9
CA

Trademark Events

Event DateEvent Description
Wednesday, April 1, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, April 1, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, September 13, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, September 13, 2019FINAL REFUSAL E-MAILED
Friday, September 13, 2019FINAL REFUSAL WRITTEN
Wednesday, September 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2019ASSIGNED TO LIE
Thursday, August 22, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 4, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, March 4, 2019INQUIRY TO SUSPENSION E-MAILED
Monday, March 4, 2019SUSPENSION INQUIRY WRITTEN
Monday, March 4, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, February 28, 2019ASSIGNED TO LIE
Wednesday, August 8, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 7, 2018ASSIGNED TO LIE
Tuesday, February 6, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 6, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, February 6, 2018SUSPENSION LETTER WRITTEN
Tuesday, February 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 31, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 23, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 23, 2017INQUIRY TO SUSPENSION E-MAILED
Wednesday, August 23, 2017SUSPENSION INQUIRY WRITTEN
Tuesday, August 22, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, February 16, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 16, 2017LETTER OF SUSPENSION E-MAILED
Thursday, February 16, 2017SUSPENSION LETTER WRITTEN
Thursday, February 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 9, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 12, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, August 12, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, August 12, 2016SUSPENSION INQUIRY WRITTEN
Thursday, August 11, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, February 5, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 5, 2016LETTER OF SUSPENSION E-MAILED
Friday, February 5, 2016SUSPENSION LETTER WRITTEN
Wednesday, January 27, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 27, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 24, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 4, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 4, 2015NON-FINAL ACTION E-MAILED
Tuesday, August 4, 2015NON-FINAL ACTION WRITTEN
Monday, August 3, 2015ASSIGNED TO EXAMINER
Tuesday, June 30, 2015PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, June 25, 2015ASSIGNED TO LIE
Wednesday, June 17, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, June 12, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 11, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

biologics therapure human plasma cryoprecipitate clinical manufacturing blood cryopaste derived from